# Lenvat (Lenvatinib) Medicine Information in Bristol and Cardiff, UK
Lenvat, containing lenvatinib as its active ingredient, is a prescription medicine used in the treatment of certain types of cancer. It belongs to the tyrosine kinase inhibitor (TKI) class of medicines and works by targeting proteins involved in tumour growth and the development of blood vessels that support cancer cells.
Patients and healthcare professionals in Bristol and Cardiff may seek reliable information about Lenvat, including its medical uses, treatment considerations, safety precautions and pharmaceutical distribution requirements.
## Understanding Lenvat Medicine
Lenvatinib may be prescribed by oncology specialists for several cancer conditions, including:
- Differentiated thyroid cancer.
- Hepatocellular carcinoma (liver cancer).
- Renal cell carcinoma (kidney cancer), in combination with another medicine.
- Advanced endometrial cancer, in combination with pembrolizumab for eligible patients.
Treatment suitability depends on the patient's diagnosis, medical history and specialist assessment.
## Lenvat Dosage and Administration
Lenvatinib is available in different capsule strengths, including 4 mg and 10 mg. The prescribed dosage depends on the cancer type, treatment combination and individual patient requirements.
Patients should follow their oncologist's instructions carefully. They should not change the dosage or discontinue treatment without medical advice.
## Lenvatinib Safety Information and Precautions
Some potential side effects associated with lenvatinib include:
- High blood pressure.
- Diarrhoea.
- Fatigue and weakness.
- Nausea and vomiting.
- Reduced appetite.
- Protein in urine.
- Changes in kidney and liver function.
Regular medical monitoring is essential during treatment. Patients should report unusual symptoms and serious adverse reactions to their healthcare professionals.
## Pharmaceutical Information for Bristol and Cardiff
Gaytri Pharma provides pharmaceutical product information and international business distribution enquiries.
Healthcare organisations and pharmaceutical businesses in Bristol and Cardiff seeking information about Lenvat should consider applicable UK pharmaceutical licensing, importation and distribution requirements.
Lenvatinib is a prescription-only cancer medicine. Patients should obtain it through authorised pharmacies and qualified healthcare professionals.
## Responsible Pharmaceutical Distribution
Reliable medicine information, appropriate product documentation and regulatory compliance are important aspects of international pharmaceutical distribution.
Gaytri Pharma aims to support international pharmaceutical business enquiries through product information and communication, subject to applicable pharmaceutical regulations.
## Contact Gaytri Pharma
Website: [https://www.medicinedropshipperindia.com/](https://www.medicinedropshipperindia.com/?utm_source=chatgpt.com)
Email:
gayetripharmaimpex@gmail.com
medicinedropshipperindia@gmail.com
Contact No.: +91 9673614585
Enquiry locations: Bristol, Cardiff and other international markets, subject to applicable pharmaceutical regulations.
